EFSA Journal (May 2017)

Re‐evaluation of sorbitan monostearate (E 491), sorbitan tristearate (E 492), sorbitan monolaurate (E 493), sorbitan monooleate (E 494) and sorbitan monopalmitate (E 495) when used as food additives

  • EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS),
  • Alicja Mortensen,
  • Fernando Aguilar,
  • Riccardo Crebelli,
  • Alessandro Di Domenico,
  • Birgit Dusemund,
  • Maria Jose Frutos,
  • Pierre Galtier,
  • David Gott,
  • Ursula Gundert‐Remy,
  • Jean‐Charles Leblanc,
  • Oliver Lindtner,
  • Peter Moldeus,
  • Pasquale Mosesso,
  • Dominique Parent‐Massin,
  • Agneta Oskarsson,
  • Ivan Stankovic,
  • Ine Waalkens‐Berendsen,
  • Rudolf Antonius Woutersen,
  • Matthew Wright,
  • Maged Younes,
  • Polly Boon,
  • Dimitrios Chrysafidis,
  • Rainer Gürtler,
  • Paul Tobback,
  • Andrea Altieri,
  • Ana Maria Rincon,
  • Claude Lambré

DOI
https://doi.org/10.2903/j.efsa.2017.4788
Journal volume & issue
Vol. 15, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract The Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion re‐evaluating the safety of sorbitan monostearate (E 491), sorbitan tristearate (E 492), sorbitan monolaurate (E 493), sorbitan monooleate (E 494) and sorbitan monopalmitate (E 495) when used as food additives. The Scientific Committee on Food (SCF) allocated an acceptable daily intake (ADI) of 25 mg/kg body weight (bw) per day for E 491, E 492 and E 495 singly or in combination; and a separate group ADI for E 493 and E 494 singly or in combination of 5 mg/kg bw per day calculated as sorbitan monolaurate in 1974. The Panel noted that after oral administration sorbitan monostearate can be either hydrolysed to its fatty acid moiety and the corresponding anhydrides of sorbitol and excreted via urine or exhaled as CO2 or excreted intact in the faeces. The Panel considered that sorbitan esters did not raise concern for genotoxicity. Based on the no observed adverse effect level (NOAEL) of 2,600 mg sorbitan monostearate/kg bw per day, taking into account the ratio between the molecular weight of sorbitan monostearate (430.62 g/mol) and sorbitan (164.16 g/mol), and applying an uncertainty factor of 100, the Panel derived a group ADI of 10 mg/kg bw per day expressed as sorbitan for sorbitan esters (E 491–495) singly or in combination. This group ADI of 10 mg sorbitan/kg bw per day is equivalent to 26 mg sorbitan monostearate/kg bw per day. The Panel concluded that the exposure at the mean and the 95th percentile level, using non‐brand‐loyal scenario, did not exceed the ADI in any of the population groups. The Panel on the request for an amendment of specifications regarding the removal of ‘congealing range’ concluded that it could be eventually replaced by another identification parameter such as melting point.

Keywords